BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

An interesting application of multi-agents applied to real-world contexts Navigating human dynamics, this is the only project I've seen that captures the intrigue of the future today Freysa freysa.ai/digital-twin?r…

Today, we’re announcing the first major discovery made by our AI Scientist with the lab in the loop: a promising new treatment for dry AMD, a major cause of blindness. Our agents generated the hypotheses, designed the experiments, analyzed the data, iterated, even made figures

A beautiful piece on the value and nuance of through-running, unifying suburban and metro rail systems - and a special section on the Lizzy Line in London, a true marvel in investment for public benefit and commute. Very impressed Benedict worksinprogress.co/issue/the-magi…

Our customer Prima Mente is using Nebius to train Pleiades, the first foundation model based on the chemical language of DNA methylation — with variants of 90M, 600M and 7B and pre-training on 1.9T tokens. At @NVIDIA #GTCParis and Viva Technology, co-founder Ravi Solanki shared more.

1/ Today we announce Pleiades, a series of epigenetic foundation models (90M→7B params) trained on 1.9T tokens of human methylation & genomic data. Pleiades accurately models epigenetics for genomic track prediction, generation & neurodegenerative disease detection from cfDNA,

Scaling laws for the brain on the way...

We’re excited to share more of our work at AAIC 2025 hosted by Alzheimer's Association over the next few days. Our founders, Ravi Solanki and Hannah Madan, will be on site in Toronto. If you would like to learn more about what we’re building at Prima Mente, please reach out. We’re also

We're excited to announce our collaboration with The Missy Project to advance AI-driven cerebral aneurysm research. This funding supports the application of our Pleiades models to the molecular biology of vascular disorders in the brain. We’ve partnered with the Atlas Surgery

A global collaboration bringing together cutting-edge AI, neurotechnology and neuroscience has been awarded a US$144,500 grant to launch the “world’s first” multiomics research initiative attempting to help predict rupture risks in intracranial aneurysms neuronewsinternational.com/multidisciplin…

Following up on our recent Google DeepMind Google Research Imperial College London AI co-scientist validation in Cell on antimicrobial resistance, I am pleased to share that a prospective validation of co-scientist hypotheses for drug repurposing in liver fibrosis has now

Excellent work by one of the best new teams in frontier AI. And I hear science may be on the roadmap 👀

Sliding window attention (SWA) is powering frontier hybrid models for efficiency. Is there something better? Introducing Phalanx, a faster and better quality drop-in replacement for sliding window attention (SWA). Phalanx is a new family of hardware and numerics-aware windowed

We’re beyond excited to share the successful launch of SANDBOX, our first clinical study in the UK. SANDBOX integrates AI, blood biomarkers, and genetics within real NHS pathways to enable earlier and more accurate detection of dementia. This study is led by Prima Mente, in

The era of human enhancement

Meet the 10 exceptional semifinalists advancing to the next round of the $1M Alzheimer's Insights AI Prize! These projects demonstrated strong scientific and technical merit, innovative application of agentic AI, and outstanding potential to reshape the future of ADRD research.

We are thrilled to be advancing as a semifinalist for the $1 Million Alzheimer’s Insights AI Prize. The Alzheimer's Disease Data Initiative Initiative supports projects that demonstrate strong scientific and technical merit, innovative application of agentic AI, and clear potential to contribute to